Cyclic Vomiting Syndrome-Related Hospitalizations Trends, Comorbidities & Health Care Costs in Children: A Population
Aravind Thavamani1, Krishna Kishore Umapathi2, Jasmine Khatana3
1Division of Pediatric Gastroenterology, Hepatology and Nutrition, UH Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH 44106, USA.
Insights
Cyclical Vomiting Syndrome (CVS) hospitalizations in children are linked to more comorbidities and rising healthcare costs. Improved management of CVS and related conditions is crucial for better outcomes and cost reduction.
Area of Science:
- Pediatric Gastroenterology
- Healthcare Economics
- Public Health
Background:
- Cyclical Vomiting Syndrome (CVS) is a debilitating condition in children.
- Understanding the clinical characteristics and healthcare burden of pediatric CVS is essential.
Purpose of the Study:
- To analyze clinical features, hospitalization trends, and healthcare resource utilization for pediatric patients diagnosed with CVS.
- To compare CVS patients with age/gender-matched controls regarding comorbidities and outcomes.
Main Methods:
- Utilized 5 Healthcare Cost and Utilization Project-Kids Inpatient Database (HCUP-KID) datasets from 2003-2016.
- Analyzed hospitalizations for patients aged 1-20 with a primary CVS diagnosis.
- Compared CVS patients to matched controls for comorbidities, outcomes, and resource utilization.
Main Results:
- 12,396 CVS hospitalizations were analyzed; mean age was 10.4 years.
- CVS was strongly associated with dysautonomia, dyspepsia, GERD, migraines, IBS, cannabis use, anxiety, and stress disorders.
- Inflation-adjusted hospitalization costs for CVS more than doubled from $3199 (2003) to $6721 (2016), totaling $84 million annually.
Conclusions:
- Hospitalized pediatric patients with CVS exhibit higher rates of DGBIs, dysautonomia, psychiatric conditions, and cannabis use.
- CVS hospitalizations in the US incur significant and increasing healthcare costs.
- Effective management of CVS and its comorbidities is necessary to mitigate healthcare expenditures and enhance patient outcomes.
Aim:
To analyze the clinical characteristics, trends in hospitalization and health care resource utilization of pediatric patients with cyclical vomiting syndrome (CVS).
Methods:
We analyzed the latest 5 Healthcare Cost and Utilization Project-Kids Inpatient Database (HCUP-KID) datasets including years 2003, 2006, 2009, 2012 and 2016 for patients aged 1-20 years with a primary diagnosis of CVS and were compared with Age/gender-matched controls for comorbidities, clinical outcomes, and healthcare resource utilization.
Results:
A total of 12,396 CVS-related hospitalizations were analyzed. The mean age of CVS patients was 10.4 ± 6.7 years. CVS was associated with dysautonomia (OR: 12.1; CI: 7.0 to 20.8), dyspepsia (OR: 11.9; CI: 8.8 to 16.03), gastroesophageal reflux disease (OR: 6.9; Confidence Interval (CI): 6.4 to 7.5), migraine headaches (OR: 6.8; CI: 5.9 to 7.7) and irritable bowel syndrome (OR: 2.08; CI: 1.2 to 4.3) (all p < 0.001). CVS was also associated with increased cannabis use (OR: 5.26, 4.6 to 5.9; p < 0.001), anxiety disorder (OR: 3.9; CI: 3.5 to 4.4) and stress reaction (OR: 3.6; CI: 2.06 to 6.3), p < 0.001. Mean CVS-related hospitalization costs (inflation adjusted) more than doubled from $3199 in 2003 to $6721 in 2016, incurring $84 million/year in total costs.
Conclusion:
Hospitalized CVS patients have increased prevalence of DGBIs, dysautonomia, psychiatric conditions and cannabis use compared to non-CVS controls. CVS-related hospitalizations in U.S. is associated with increasing health care costs. Better management of CVS and comorbid conditions is warranted to reduce health care costs and improve outcomes.
Related Concept Videos
Pathophysiology of Vomiting
Bulimia Nervosa
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Factors Affecting Illness
For instance, risk factors are connected to illness,...

